Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes
Annals of Laboratory Medicine · 2023
DOI: 10.3343/alm.2023.43.4.325 ↗Kurz gefasst
Editorial in der Zeitschrift Annals of Laboratory Medicine, 2023. Verfasst von Minjeong Nam und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory Medicine, Korea University College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Since the introduction of the Luminex technique to detect donor-specific antibodies (DSAs) in kidney transplantation, efforts have been made to determine the risk of pre-operative low-level DSAs. The risk of low-level DSAs can be stratified by the mean fluorescence intensity (MFI), based on the highest level or sum [1]. However, the relative amount of antigen expressed on Luminex beads for each HLA locus varies from that expressed in vivo [2]. Therefore, caution is needed when applying the same MFI criteria to each HLA locus. Accordingly, the flow cytometric crossmatch test, which detects the actual binding of a DSA to donor lymphocytes, remains an important pre-transplantation test despite recognized limitations such as inter-laboratory and person-to-person variations or false positives due to non-HLA antibodies [3]. Therefore, it is meaningful to analyze the clinical impact of pre-operative low-level DSAs determined by a positive Luminex result but negative flow cytometric crossmatch (PLNF) on kidney transplantation outcomes. Previous studies demonstrating these effects reported diverse results [4, 5]. In 2012, a meta-analysis including seven studies concluded that the risk of antibody-mediated rejection (AMR) and graft failure increased in patients with PLNF results compared to that in patients without DSAs, even when using the Luminex assay [4]. However, a subsequent meta-analysis published in 2019 also analyzing seven studies showed no significant increase in the risk of acute rejection, 1-year graft survival, or 5-year graft survival [5]. The major contributor to these discrepant results is the use of different criteria for selecting patients among studies. First, the type of kidney donor could be different (living vs. dece ased-donor). Clinical outcomes of deceased-donor transplantation are known to be worse than those of living-donor transplantation [6, 7]. Second, the inclusion or exclusion of patients with pre-operative desensitization treatment can affect the study results [8-10]. Third, the collection of serum before or after desensitization prior to transplantation will have a large impact. DSA levels were found to be lower for samples collected after desensitization, which would result in more favorable clinical outcomes as the risk of DSAs is minimized [8, 11]. Conversely, studies using sera after desensitization or excluding patients who underwent desensitization indicated an increase in the risk of AMR, although the risk of graft failure did not increase [9, 11]. In this issue of Annals of Laboratory Medicine, Lee, et al. [12] reported the results of an analysis of 1,090 kidney transplantation patients (629 living and 398 deceased donors), wherein 178 patients (127 living and 51 deceased donors) had undergone desensitization before transplantation. In these 178 pa1 / 1 CROSSMARK_logo_3_Test
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory Medicine, Korea University College of Medicine, Seoul, Korea.
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, Korea.
ORCID-Profile: Minjeong Nam, Eun Young Song
Zitieren
APA
Nam, M., & Song, E. Y. (2023). Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes. Annals of Laboratory Medicine. https://doi.org/10.3343/alm.2023.43.4.325
Vancouver
Nam M, Song EY. Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes. Annals of Laboratory Medicine. 2023. doi:10.3343/alm.2023.43.4.325
BibTeX
@article{Nam2023,
author = {Nam, Minjeong and Song, Eun Young},
title = {Impact of Low-level Donor-specific Antibody Determined With a Positive Luminex and Negative Flow Cytometric Crossmatch on Kidney Transplantation Outcomes},
journal = {Annals of Laboratory Medicine},
year = {2023},
doi = {10.3343/alm.2023.43.4.325}
}
EUVIMED